{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0008283",
      "entity_text" : "proliferation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5284616",
      "entity_text" : "rapamycin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In addition, through the synergistic antiangiogenic effects, very low-dose combinatorial use of vinblastine (VBL) and rapamycin (RAP) was demonstrated to inhibit the proliferation of the endothelial cells much more effectively than single drug treatment both in vitro and in vivo [XREF_BIBR].",
  "reading_complete" : "2020-08-03T12:16:36Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:12:11Z",
  "trigger" : "inhibit",
  "evidence" : [ "rapamycin (RAP) was demonstrated to inhibit the proliferation" ],
  "pmc_id" : "3403482",
  "score" : 0
}